9122B |
Bupropion and Metabolite Screen, Blood |
9122SP |
Bupropion and Metabolite Screen, Serum/Plasma |
9122TI |
Bupropion and Metabolite Screen, Tissue |
9122U |
Bupropion and Metabolite Screen, Urine |
9142B |
Cyanide Screen, Blood |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9182B |
Haloperidol Screen, Blood |
9182SP |
Haloperidol Screen, Serum/Plasma |
9190B |
Ketoacidosis Screen, Postmortem, Blood (Forensic) |
9190FL |
Ketoacidosis Screen, Postmortem, Fluid (Forensic) |
9205SP |
Dextro / Levo Methorphan Screen, Serum/Plasma |
9205U |
Dextro / Levo Methorphan Screen - Total, Urine |
9206U |
Dextrorphan / Levorphanol Screen - Total, Urine |
9249B |
Pseudoephedrine vs Ephedrine Differentiation Screen, Blood |
9249U |
Pseudoephedrine vs Ephedrine Differentiation Screen, Urine |
9254B |
Quinine/Quinidine Screen, Blood |
9261B |
Scopolamine Screen, Blood |
9261SP |
Scopolamine Screen, Serum/Plasma |
9261U |
Scopolamine Screen, Urine |
9306U |
Anabolic Steroids Screen, Urine |
9318U |
Diuretics Screen, Urine |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9404B |
Nicotine and Metabolite Screen, Blood |
9404SP |
Nicotine and Metabolite Screen, Serum/Plasma |
9404U |
Nicotine and Metabolite with Anabasine Screen, Urine |